Albanian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

glutamic/kanceri

Lidhja ruhet në kujtesën e fragmenteve
Faqja 1 nga 55 rezultatet

Method for treating cervical intraepithelial neoplasia using poly-gamma- glutamic acid

Vetëm përdoruesit e regjistruar mund të përkthejnë artikuj
Identifikohuni Regjistrohu
TECHNICAL FIELD The present invention relates to a method for treating cervical intraepithelial neoplasia using poly-gamma-glutamic acid, and more particularly, to a method for treating cervical intraepithelial neoplasia, comprising administering to a patient with cervical intraepithelial neoplasia

N-[N-(tetrahydropyrido[2,3-D]pyrimidinylmethyl)-aminomethylbenzo yl]glutamic acid derivatives as neoplastic growth inhibitors

Vetëm përdoruesit e regjistruar mund të përkthejnë artikuj
Identifikohuni Regjistrohu
The present invention pertains to the individual diastereomers and to the diastereomeric mixture of glutamic acid derivatives of the formula: ##STR1## in which: R.sup.1 is hydrogen, alkyl of 1 to 6 carbon atoms, or alkanoyl of 1 to 6 carbon atoms; R.sup.2 is hydrogen or a carboxy protecting

Polysaccharidic esters of N-derivatives of glutamic acid

Vetëm përdoruesit e regjistruar mund të përkthejnë artikuj
Identifikohuni Regjistrohu
FIELD OF THE INVENTION The present invention relates to new products, namely polysaccharidic esters of N-derivatives of glutamic acid (N-GA). Their use as antiproliferatives in pharmaceutics is herein described. PRIOR ART Several modified polysaccharides have been described in the art. They are

Adjuvant composition containing poly-gamma-glutamic acid-chitosan nanoparticles

Vetëm përdoruesit e regjistruar mund të përkthejnë artikuj
Identifikohuni Regjistrohu
TECHNICAL FIELD The present invention relates to an adjuvant composition containing poly-gamma-glutamic acid-chitosan nanoparticles and a vaccine composition containing the adjuvant composition, and more particularly to an adjuvant composition containing nanoparticles prepared by ionic bonding

Derivatives of aspartic acid and glutamic acid having anticholecystokinin activity

Vetëm përdoruesit e regjistruar mund të përkthejnë artikuj
Identifikohuni Regjistrohu
This invention relates to amino acid derivatives, and more particularly to amino acid derivatives which possess anti-cholecystokinin activity. The invention also relates to methods for preparing such cholecystokinin antagonists and to compounds which are useful as intermediates in such
The subject of the present invention is compounds with activities antagonistic towards gastrin or other peptides related thereto, which can be represented by the general formula indicated below: ##STR2## in which r is from 1 to 3, and R.sub.1 is selected from mono-, di-substituted phenyl groups, in
The present invention relates to novel derivatives of D,L-glutamic acid and D,L-aspartic acid which may be represented by the general formula given below ##STR2## where n is 1 or 2, R.sub.1 is a mono- or di-substituted phenyl group substituted with halogens such as chlorine and fluorine or with a

Pyrimidinyl-glutamic acid derivatives

Vetëm përdoruesit e regjistruar mund të përkthejnë artikuj
Identifikohuni Regjistrohu
BACKGROUND OF THE INVENTION The folic acid antimetabolites aminopterin and amethopterin (also known as 10-methylaminopterin or methotrexate) are antineoplastic agents. These compounds inhibit enzymatic conversions involving metabolic derivatives of folic acid. Amethopterin, for example, inhibits

Mini-gastrin analogue, in particular for use in CCK2 receptor positive tumour diagnosis and/or treatment

Vetëm përdoruesit e regjistruar mund të përkthejnë artikuj
Identifikohuni Regjistrohu
BACKGROUND OF THE INVENTION Field of the Invention The present invention relates to a mini-gastrin analogue and to its use in CCK2 receptor positive tumor diagnosis and/or treatment. G protein-coupled receptors (GPCR) are used as target proteins for radiolabelled peptides since the early 90's. The

N-(4-(1-hydroxy-3-(5 ,6,7,8-tetrahydropyrido(2,3,-d)-pyrimidin-6-yl)prop-2-yl)benzoyl)glutamic acid derivatives

Vetëm përdoruesit e regjistruar mund të përkthejnë artikuj
Identifikohuni Regjistrohu
The present invention pertains to the individual diastereomers and to the diastereomeric mixture of glutamic acid derivatives of the formula: ##STR1## in which: R.sup.1 is --OH or --NH.sub.2 ; R.sup.2 is hydrogen or a carboxy protecting group; R.sup.3 is hydrogen or a hydroxy protecting

Conjugates of D-glutamic acid: D-lysine copolymer and certain biochemicals

Vetëm përdoruesit e regjistruar mund të përkthejnë artikuj
Identifikohuni Regjistrohu
BACKGROUND OF THE INVENTION D-GL (D-glutamic acid:D-lysine copolymer) conjugates have been described at considerable length and various applications of D-GL conjugates of various immunologically reactive species have been reported. The following U.S. Pat. Nos. describe in considerable detail the

Producing highly specific, low cross-reactive antibody by immunizing with copolymer of D-glutamic acid and lysine

Vetëm përdoruesit e regjistruar mund të përkthejnë artikuj
Identifikohuni Regjistrohu
FIELD OF ART This invention relates to an improved antibody, antiserum containing such antibody and clone for the production of such an antibody and also relates to their production. This invention further relates to a method of immunoassay using such antibody or antiserum. PRIOR ART For example,

L-glutamic acid derivatives

Vetëm përdoruesit e regjistruar mund të përkthejnë artikuj
Identifikohuni Regjistrohu
This invention pertains to derivatives of L-glutamic acid which are antineoplastic agents, to their preparation and use, and to intermediates useful in their preparation. BACKGROUND OF THE INVENTION The folic acid antimetabolites aminopterin and amethopterin (also known as 10-methylaminopterin or

L-glutamic acid derivatives

Vetëm përdoruesit e regjistruar mund të përkthejnë artikuj
Identifikohuni Regjistrohu
This invention pertains to derivatives of L-glutamic acid which are antineoplastic agents, to their preparation and use, and to intermediates useful in their preparation. BACKGROUND OF THE INVENTION The folic acid antimetabolites aminopterin and amethopterin (also known as 10-methylaminopterin or

L-glutamic acid derivatives

Vetëm përdoruesit e regjistruar mund të përkthejnë artikuj
Identifikohuni Regjistrohu
This invention pertains to derivatives of L-glutamic acid which are antineoplastic agents, to their preparation and use, and to intermediates useful in their preparation. BACKGROUND OF THE INVENTION The folic acid antimetabolites aminopterin and amethopterin (also known as 10-methylaminopterin or
Bashkohuni në faqen
tonë në facebook

Baza e të dhënave më e plotë e bimëve medicinale e mbështetur nga shkenca

  • Punon në 55 gjuhë
  • Kurime bimore të mbështetura nga shkenca
  • Njohja e bimëve nga imazhi
  • Harta GPS interaktive - etiketoni bimët në vendndodhje (së shpejti)
  • Lexoni botime shkencore në lidhje me kërkimin tuaj
  • Kërkoni bimë medicinale nga efektet e tyre
  • Organizoni interesat tuaja dhe qëndroni në azhurnim me kërkimet e lajmeve, provat klinike dhe patentat

Shkruani një simptomë ose një sëmundje dhe lexoni në lidhje me barërat që mund të ndihmojnë, shtypni një barishte dhe shikoni sëmundjet dhe simptomat që përdoren kundër.
* I gjithë informacioni bazohet në kërkimin shkencor të botuar

Google Play badgeApp Store badge